| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.36B | 31.71B | 25.78B | 18.57B | 15.94B | 13.57B |
| Gross Profit | 8.34B | 8.87B | 7.82B | 6.05B | 5.03B | 4.35B |
| EBITDA | 4.07B | 5.20B | 3.61B | 3.34B | 2.57B | 2.05B |
| Net Income | 2.05B | 2.97B | 1.67B | 1.48B | 1.09B | 976.00M |
Balance Sheet | ||||||
| Total Assets | 26.33B | 31.62B | 24.67B | 19.55B | 16.44B | 14.19B |
| Cash, Cash Equivalents and Short-Term Investments | 12.38B | 16.38B | 12.33B | 8.78B | 6.98B | 6.74B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 17.27B | 20.67B | 15.88B | 12.41B | 9.78B | 8.79B |
| Stockholders Equity | 7.90B | 9.39B | 7.74B | 6.38B | 6.20B | 5.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.98B | 5.11B | 2.81B | 817.00M | 2.01B |
| Operating Cash Flow | 0.00 | 7.02B | 5.48B | 2.99B | 1.46B | 2.57B |
| Investing Cash Flow | 0.00 | -1.24B | -1.05B | -604.00M | -1.07B | -459.82M |
| Financing Cash Flow | 0.00 | -1.73B | -881.00M | -586.00M | -149.00M | -191.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥49.26B | 15.18 | ― | 0.90% | 23.01% | 79.70% | |
75 Outperform | ¥29.94B | 21.60 | ― | 0.38% | 19.28% | 113.67% | |
72 Outperform | ¥5.59B | 5.74 | ― | ― | 6.08% | 48.90% | |
67 Neutral | ¥11.51B | 8.66 | ― | ― | 22.47% | -28.97% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥10.56B | 6.53 | ― | 1.09% | -1.25% | ― |